A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy ...

In a conversation with The Regulatory Review, Ropes & Gray partner David Peloquin discusses how clinical research studies are ...

In response to a recent article about an interesting biotechnology stock, a reader recently asked me how to handle the ...

PainReform ( (PRFX) ) has provided an update. PainReform announced that its Phase 3 clinical trial for PRF-110 did not meet ...

Recently, a study has shed light on the potential of suvorexant, a drug commonly used to treat insomnia, as a possible tool in the fight against Alzheimer's disease. This finding s ...

Sundayjn to highlight the potential of Bubble Continuous Positive Airway Pressure (bCPAP), a locally manufactured, low-cost ...

Given its low valuation and the seeming overreaction in the markets to the recent trial results, this is a stock that could ...

A common deworming drug used in dogs and cats called fenbendazole may help to cure cancer in humans, but doctors urge caution ...

all kabaddi teams 2023 players list BTK inhibitors "illustration" Dupixent, a blockbuster new drug with a potential of 10 ...

what is yorker in cricket Merck's P2X3 receptor blocker gefapixant succeeds in two key Phase 3 clinical trials Sanofi/Regeneron Dupixent successfully treats severe atopic dermatitis in children in ...

Twin boys from Roscommon who are battling a life-limiting illness, are hoping to take part in a groundbreaking clinical trial ...

Kineko tokenomics Nirsevimab, a monoclonal antibody for the prevention of respiratory syncytial virus, is included in the breakthrough therapy program ...